Outlook Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-12-31

Reported

2026-02-17

Disclosure lag

48 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Outlook Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001649989/2026-07-26
Event ID	#27695

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001104659-26-016554",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "Q1",
  "fiscal_year": 2026,
  "form": "10-Q",
  "mapped_tag_share": 0.04282115869017632,
  "metrics": {
    "cash_and_equivalents": 8677424,
    "earnings_per_share_basic": -0.38,
    "earnings_per_share_diluted": -0.38,
    "gross_profit": -1237459,
    "net_income": -23058135,
    "operating_cash_flow": -14939111,
    "operating_income": -13483952,
    "shareholders_equity": -38549465,
    "shares_outstanding": 64556570,
    "total_assets": 18238574,
    "total_liabilities": 56788039
  },
  "metrics_reported": 11,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-02-17T00:00:00Z